Expression and regulation of SETBP1 in the song system of male zebra finches (Taeniopygia guttata) during singing.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : Nature Publishing Group, copyright 2011-
    • Subject Terms:
    • Abstract:
      Rare de novo heterozygous loss-of-function SETBP1 variants lead to a neurodevelopmental disorder characterized by speech deficits, indicating a potential involvement of SETBP1 in human speech. However, the expression pattern of SETBP1 in brain regions associated with vocal learning remains poorly understood, along with the underlying molecular mechanisms linking it to vocal production. In this study, we examined SETBP1 expression in the brain of male zebra finches, a well-established model for studying vocal production learning. We demonstrated that zebra finch SETBP1 exhibits a greater number of exons and isoforms compared to its human counterpart. We characterized a SETBP1 antibody and showed that SETBP1 colocalized with FoxP1, FoxP2, and Parvalbumin in key song nuclei. Moreover, SETBP1 expression in neurons in Area X is significantly higher in zebra finches singing alone, than those singing courtship song to a female, or non-singers. Importantly, we found a distinctive neuronal protein expression of SETBP1 and FoxP2 in Area X only in zebra finches singing alone, but not in the other conditions. We demonstrated SETBP1´s regulatory role on FoxP2 promoter activity in vitro. Taken together, these findings provide compelling evidence for SETBP1 expression in brain regions to be crucial for vocal learning and its modulation by singing behavior.
      Competing Interests: Declarations. Competing interests: The authors declare no competing interests.
      (© 2024. The Author(s).)
    • References:
      J Neurosci. 2019 Dec 4;39(49):9782-9796. (PMID: 31641053)
      Mol Autism. 2023 Feb 20;14(1):8. (PMID: 36805818)
      Genes Brain Behav. 2017 Jul;16(6):635-642. (PMID: 28488276)
      Nat Genet. 2010 Jun;42(6):483-5. (PMID: 20436468)
      Mol Cell Biol. 1992 Aug;12(8):3346-55. (PMID: 1630450)
      Nature. 2001 Oct 4;413(6855):519-23. (PMID: 11586359)
      Brain Res. 2001 Nov 2;917(2):235-52. (PMID: 11640910)
      PLoS One. 2014 Jun 13;9(6):e99678. (PMID: 24926893)
      Nat Med. 2006 Apr;12(4):401-9. (PMID: 16582916)
      Mol Cell Biol. 2004 Jan;24(2):809-22. (PMID: 14701752)
      Mol Psychiatry. 2019 Jul;24(7):1065-1078. (PMID: 29463886)
      Nat Commun. 2021 Jun 30;12(1):4050. (PMID: 34193871)
      Hum Mutat. 2017 Nov;38(11):1542-1554. (PMID: 28741757)
      J Cell Mol Med. 2023 Nov;27(22):3565-3577. (PMID: 37872881)
      Eur J Biochem. 2001 Mar;268(5):1340-51. (PMID: 11231286)
      Eur J Neurosci. 2007 Mar;25(6):1663-8. (PMID: 17408434)
      BMC Med Genomics. 2016 Jul 19;9(1):42. (PMID: 27435318)
      Genomics. 1995 Jan 20;25(2):462-8. (PMID: 7789979)
      Nat Rev Neurosci. 2010 Nov;11(11):747-59. (PMID: 20959859)
      Am J Med Genet A. 2017 Dec;173(12):3172-3181. (PMID: 28884888)
      J Neurosci. 2004 Mar 31;24(13):3164-75. (PMID: 15056696)
      Eur J Med Genet. 2015 Aug;58(8):369-71. (PMID: 26096993)
      PLoS Biol. 2007 Dec;5(12):e321. (PMID: 18052609)
      Nat Methods. 2012 Jun 28;9(7):676-82. (PMID: 22743772)
      Mol Psychiatry. 2023 Apr;28(4):1647-1663. (PMID: 36117209)
      Nat Commun. 2018 Jun 6;9(1):2192. (PMID: 29875417)
      Nat Commun. 2023 Jun 3;14(1):3212. (PMID: 37270547)
      Eur J Hum Genet. 2021 Aug;29(8):1198-1205. (PMID: 33867525)
      Front Mol Neurosci. 2017 May 01;10:112. (PMID: 28507505)
      Neurology. 2020 May 19;94(20):e2148-e2167. (PMID: 32345733)
      J Comp Neurol. 2015 Jun 15;523(9):1318-40. (PMID: 25556631)
      Gigascience. 2017 Oct 1;6(10):1-16. (PMID: 29020750)
      Dev Neurobiol. 2019 Jun;79(6):578-595. (PMID: 31207118)
      Sci Rep. 2020 Mar 16;10(1):4787. (PMID: 32179863)
      Front Mol Neurosci. 2018 Feb 21;11:47. (PMID: 29515369)
      Mol Cell Neurosci. 2016 Jul;74:96-105. (PMID: 27105823)
      Br J Haematol. 2007 Jan;136(2):294-6. (PMID: 17233820)
      PLoS One. 2024 Jan 2;19(1):e0296328. (PMID: 38165902)
      Hum Mol Genet. 2016 Feb 1;25(3):546-57. (PMID: 26647308)
      Front Neural Circuits. 2013 Feb 28;7:24. (PMID: 23450800)
      Nat Genet. 2014 Oct;46(10):1063-71. (PMID: 25217958)
      Nat Genet. 2013 Jan;45(1):18-24. (PMID: 23222956)
      J Neurosci. 2015 Feb 18;35(7):2885-94. (PMID: 25698728)
      J Hum Genet. 2023 Dec;68(12):867-874. (PMID: 37737486)
      Eur J Hum Genet. 2021 Aug;29(8):1216-1225. (PMID: 33907317)
      Hum Mutat. 2018 Jul;39(7):1014-1023. (PMID: 29688601)
      Med Res Arch. 2020 Jun;8(6):. (PMID: 34164576)
      PLoS Genet. 2017 Mar 27;13(3):e1006683. (PMID: 28346496)
      Annu Rev Neurosci. 1999;22:567-631. (PMID: 10202549)
      Front Neurosci. 2022 May 24;16:813430. (PMID: 35685777)
      Science. 2021 Feb 12;371(6530):. (PMID: 33574185)
    • Accession Number:
      0 (Forkhead Transcription Factors)
      0 (Carrier Proteins)
      0 (Nuclear Proteins)
    • Publication Date:
      Date Created: 20241123 Date Completed: 20241123 Latest Revision: 20241126
    • Publication Date:
      20241202
    • Accession Number:
      PMC11585544
    • Accession Number:
      10.1038/s41598-024-75353-w
    • Accession Number:
      39580495